Drugs / Anti-human CD7 CAR-NK cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07117175 | Sep 2025 → Dec 2027 expected | hematopoietic and lymphoid cell neoplasm | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-human CD7 CAR-NK cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07117175 ↗ |
| Modality | Cell therapy | “anti-human CD7 CAR-NK cells” NCT07117175 ↗ |
| Route | Intravenous | “Intravenous infusion of anti-human CD7 CAR-NK cell injection” NCT07117175 ↗ |
| Target | CD7 | “anti-human CD7” NCT07117175 ↗ |